The global market for Telmisartan and Hydrochlorothiazide Drug was estimated to be worth US$ 547 million in 2023 and is forecast to a readjusted size of US$ 800.5 million by 2030 with a CAGR of 6.2% during the forecast period 2024-2030

Telmisartan and Hydrochlorothiazide Drug - Market

Telmisartan and Hydrochlorothiazide Drug is a combination product that contains two medications used to lower hypertension (high blood pressure): telmisartan and hydrochlorothiazide. It is used to treat high blood pressure for people who require treatment with both telmisartan and hydrochlorothiazide.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Telmisartan and Hydrochlorothiazide Drug, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Telmisartan and Hydrochlorothiazide Drug by region & country, by Type, and by Application.

The Telmisartan and Hydrochlorothiazide Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Telmisartan and Hydrochlorothiazide Drug.

Market Segmentation

Scope of Telmisartan and Hydrochlorothiazide Drug - Market Report

Report Metric	Details
Report Name	Telmisartan and Hydrochlorothiazide Drug - Market
Forecasted market size in 2030	US$ 800.5 million
CAGR	6.2%
Forecasted years	2024 - 2030
Segment by Type:	80 mg/12.5 mg Tablets 40 mg/12.5 mg Tablets 80 mg/25 mg Tablets
Segment by Application	High Blood Pressure (Hypertension) Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boehringer Ingelheim, Teva, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Alembic Pharmaceutical, Torrent Pharmaceuticals, Macleods, Zydus Pharmaceuticals, Aurobindo, Huahai Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Telmisartan and Hydrochlorothiazide Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Telmisartan and Hydrochlorothiazide Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Telmisartan and Hydrochlorothiazide Drug in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Telmisartan and Hydrochlorothiazide Drug - Market size in 2030?

Ans: The Telmisartan and Hydrochlorothiazide Drug - Market size in 2030 will be US$ 800.5 million.

Who are the main players in the Telmisartan and Hydrochlorothiazide Drug - Market report?

Ans: The main players in the Telmisartan and Hydrochlorothiazide Drug - Market are Boehringer Ingelheim, Teva, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Alembic Pharmaceutical, Torrent Pharmaceuticals, Macleods, Zydus Pharmaceuticals, Aurobindo, Huahai Pharmaceutical

What are the Application segmentation covered in the Telmisartan and Hydrochlorothiazide Drug - Market report?

Ans: The Applications covered in the Telmisartan and Hydrochlorothiazide Drug - Market report are High Blood Pressure (Hypertension), Others

What are the Type segmentation covered in the Telmisartan and Hydrochlorothiazide Drug - Market report?

Ans: The Types covered in the Telmisartan and Hydrochlorothiazide Drug - Market report are 80 mg/12.5 mg Tablets, 40 mg/12.5 mg Tablets, 80 mg/25 mg Tablets

1 Market Overview

1.1 Telmisartan and Hydrochlorothiazide Drug Product Introduction

1.2 Global Telmisartan and Hydrochlorothiazide Drug Market Size Forecast

1.2.1 Global Telmisartan and Hydrochlorothiazide Drug Sales Value (2019-2030)

1.2.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume (2019-2030)

1.2.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Price (2019-2030)

1.3 Telmisartan and Hydrochlorothiazide Drug Market Trends & Drivers

1.3.1 Telmisartan and Hydrochlorothiazide Drug Industry Trends

1.3.2 Telmisartan and Hydrochlorothiazide Drug Market Drivers & Opportunity

1.3.3 Telmisartan and Hydrochlorothiazide Drug Market Challenges

1.3.4 Telmisartan and Hydrochlorothiazide Drug Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Telmisartan and Hydrochlorothiazide Drug Players Revenue Ranking (2023)

2.2 Global Telmisartan and Hydrochlorothiazide Drug Revenue by Company (2019-2024)

2.3 Global Telmisartan and Hydrochlorothiazide Drug Players Sales Volume Ranking (2023)

2.4 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Company Players (2019-2024)

2.5 Global Telmisartan and Hydrochlorothiazide Drug Average Price by Company (2019-2024)

2.6 Key Manufacturers Telmisartan and Hydrochlorothiazide Drug Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Telmisartan and Hydrochlorothiazide Drug Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Telmisartan and Hydrochlorothiazide Drug

2.9 Telmisartan and Hydrochlorothiazide Drug Market Competitive Analysis

2.9.1 Telmisartan and Hydrochlorothiazide Drug Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Telmisartan and Hydrochlorothiazide Drug Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Telmisartan and Hydrochlorothiazide Drug as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 80 mg/12.5 mg Tablets

3.1.2 40 mg/12.5 mg Tablets

3.1.3 80 mg/25 mg Tablets

3.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Type

3.2.1 Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Value, by Type (2019-2030)

3.2.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Value, by Type (%) (2019-2030)

3.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Type

3.3.1 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume, by Type (2019-2030)

3.3.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume, by Type (%) (2019-2030)

3.4 Global Telmisartan and Hydrochlorothiazide Drug Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 High Blood Pressure (Hypertension)

4.1.2 Others

4.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Application

4.2.1 Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Value, by Application (2019-2030)

4.2.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Value, by Application (%) (2019-2030)

4.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Application

4.3.1 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume, by Application (2019-2030)

4.3.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume, by Application (%) (2019-2030)

4.4 Global Telmisartan and Hydrochlorothiazide Drug Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region

5.1.1 Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region (2019-2024)

5.1.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region (2025-2030)

5.1.4 Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region (%), (2019-2030)

5.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region

5.2.1 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region (2019-2024)

5.2.3 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region (2025-2030)

5.2.4 Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region (%), (2019-2030)

5.3 Global Telmisartan and Hydrochlorothiazide Drug Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

5.4.2 North America Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

5.5.2 Europe Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

5.6.2 Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

5.7.2 South America Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

5.8.2 Middle East & Africa Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Value

6.2.1 Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

6.2.2 Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

6.3.2 United States Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Telmisartan and Hydrochlorothiazide Drug Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

6.4.2 Europe Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Telmisartan and Hydrochlorothiazide Drug Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

6.5.2 China Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

6.5.3 China Telmisartan and Hydrochlorothiazide Drug Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

6.6.2 Japan Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Telmisartan and Hydrochlorothiazide Drug Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

6.7.2 South Korea Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Telmisartan and Hydrochlorothiazide Drug Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

6.8.2 Southeast Asia Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Telmisartan and Hydrochlorothiazide Drug Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019-2030

6.9.2 India Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

6.9.3 India Telmisartan and Hydrochlorothiazide Drug Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Boehringer Ingelheim

7.1.1 Boehringer Ingelheim Company Information

7.1.2 Boehringer Ingelheim Introduction and Business Overview

7.1.3 Boehringer Ingelheim Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Boehringer Ingelheim Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.1.5 Boehringer Ingelheim Recent Development

7.2 Teva

7.2.1 Teva Company Information

7.2.2 Teva Introduction and Business Overview

7.2.3 Teva Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Teva Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.2.5 Teva Recent Development

7.3 Lupin Pharmaceuticals

7.3.1 Lupin Pharmaceuticals Company Information

7.3.2 Lupin Pharmaceuticals Introduction and Business Overview

7.3.3 Lupin Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Lupin Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.3.5 Lupin Pharmaceuticals Recent Development

7.4 Mylan Pharmaceuticals

7.4.1 Mylan Pharmaceuticals Company Information

7.4.2 Mylan Pharmaceuticals Introduction and Business Overview

7.4.3 Mylan Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Mylan Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.4.5 Mylan Pharmaceuticals Recent Development

7.5 Alembic Pharmaceutical

7.5.1 Alembic Pharmaceutical Company Information

7.5.2 Alembic Pharmaceutical Introduction and Business Overview

7.5.3 Alembic Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Alembic Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.5.5 Alembic Pharmaceutical Recent Development

7.6 Torrent Pharmaceuticals

7.6.1 Torrent Pharmaceuticals Company Information

7.6.2 Torrent Pharmaceuticals Introduction and Business Overview

7.6.3 Torrent Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Torrent Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.6.5 Torrent Pharmaceuticals Recent Development

7.7 Macleods

7.7.1 Macleods Company Information

7.7.2 Macleods Introduction and Business Overview

7.7.3 Macleods Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Macleods Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.7.5 Macleods Recent Development

7.8 Zydus Pharmaceuticals

7.8.1 Zydus Pharmaceuticals Company Information

7.8.2 Zydus Pharmaceuticals Introduction and Business Overview

7.8.3 Zydus Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Zydus Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.8.5 Zydus Pharmaceuticals Recent Development

7.9 Aurobindo

7.9.1 Aurobindo Company Information

7.9.2 Aurobindo Introduction and Business Overview

7.9.3 Aurobindo Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Aurobindo Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.9.5 Aurobindo Recent Development

7.10 Huahai Pharmaceutical

7.10.1 Huahai Pharmaceutical Company Information

7.10.2 Huahai Pharmaceutical Introduction and Business Overview

7.10.3 Huahai Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Huahai Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Product Offerings

7.10.5 Huahai Pharmaceutical Recent Development

8 Industry Chain Analysis

8.1 Telmisartan and Hydrochlorothiazide Drug Industrial Chain

8.2 Telmisartan and Hydrochlorothiazide Drug Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Telmisartan and Hydrochlorothiazide Drug Sales Model

8.5.2 Sales Channel

8.5.3 Telmisartan and Hydrochlorothiazide Drug Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Boehringer Ingelheim

TEVA

Lupin Pharmaceuticals

Mylan Pharmaceuticals

Alembic Pharmaceutical

Torrent Pharmaceuticals

Macleods

Zydus Pharmaceuticals

Aurobindo

Huahai Pharmaceutical

List of Tables

Table 1. Telmisartan and Hydrochlorothiazide Drug Market Trends

Table 2. Telmisartan and Hydrochlorothiazide Drug Market Drivers & Opportunity

Table 3. Telmisartan and Hydrochlorothiazide Drug Market Challenges

Table 4. Telmisartan and Hydrochlorothiazide Drug Market Restraints

Table 5. Global Telmisartan and Hydrochlorothiazide Drug Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Telmisartan and Hydrochlorothiazide Drug Revenue Market Share by Company (2019-2024)

Table 7. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Telmisartan and Hydrochlorothiazide Drug Price by Company (2019-2024) & (USD/Unit)

Table 10. Key Manufacturers Telmisartan and Hydrochlorothiazide Drug Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Telmisartan and Hydrochlorothiazide Drug Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Telmisartan and Hydrochlorothiazide Drug

Table 13. Global Telmisartan and Hydrochlorothiazide Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Telmisartan and Hydrochlorothiazide Drug as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Telmisartan and Hydrochlorothiazide Drug Price by Type (2019-2024) & (USD/Unit)

Table 27. Global Telmisartan and Hydrochlorothiazide Drug Price by Type (2025-2030) & (USD/Unit)

Table 28. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Telmisartan and Hydrochlorothiazide Drug Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Telmisartan and Hydrochlorothiazide Drug Price by Application (2019-2024) & (USD/Unit)

Table 39. Global Telmisartan and Hydrochlorothiazide Drug Price by Application (2025-2030) & (USD/Unit)

Table 40. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region (2019-2024) & (%)

Table 44. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Region (2025-2030) & (%)

Table 45. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region (2019-2024) & (%)

Table 49. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Region (2025-2030) & (%)

Table 50. Global Telmisartan and Hydrochlorothiazide Drug Average Price by Region (2019-2024) & (USD/Unit)

Table 51. Global Telmisartan and Hydrochlorothiazide Drug Average Price by Region (2025-2030) & (USD/Unit)

Table 52. Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Volume, (2025-2030) & (K Units)

Table 57. Boehringer Ingelheim Company Information

Table 58. Boehringer Ingelheim Introduction and Business Overview

Table 59. Boehringer Ingelheim Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 60. Boehringer Ingelheim Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 61. Boehringer Ingelheim Recent Development

Table 62. Teva Company Information

Table 63. Teva Introduction and Business Overview

Table 64. Teva Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 65. Teva Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 66. Teva Recent Development

Table 67. Lupin Pharmaceuticals Company Information

Table 68. Lupin Pharmaceuticals Introduction and Business Overview

Table 69. Lupin Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 70. Lupin Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 71. Lupin Pharmaceuticals Recent Development

Table 72. Mylan Pharmaceuticals Company Information

Table 73. Mylan Pharmaceuticals Introduction and Business Overview

Table 74. Mylan Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 75. Mylan Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 76. Mylan Pharmaceuticals Recent Development

Table 77. Alembic Pharmaceutical Company Information

Table 78. Alembic Pharmaceutical Introduction and Business Overview

Table 79. Alembic Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 80. Alembic Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 81. Alembic Pharmaceutical Recent Development

Table 82. Torrent Pharmaceuticals Company Information

Table 83. Torrent Pharmaceuticals Introduction and Business Overview

Table 84. Torrent Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 85. Torrent Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 86. Torrent Pharmaceuticals Recent Development

Table 87. Macleods Company Information

Table 88. Macleods Introduction and Business Overview

Table 89. Macleods Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 90. Macleods Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 91. Macleods Recent Development

Table 92. Zydus Pharmaceuticals Company Information

Table 93. Zydus Pharmaceuticals Introduction and Business Overview

Table 94. Zydus Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 95. Zydus Pharmaceuticals Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 96. Zydus Pharmaceuticals Recent Development

Table 97. Aurobindo Company Information

Table 98. Aurobindo Introduction and Business Overview

Table 99. Aurobindo Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 100. Aurobindo Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 101. Aurobindo Recent Development

Table 102. Huahai Pharmaceutical Company Information

Table 103. Huahai Pharmaceutical Introduction and Business Overview

Table 104. Huahai Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 105. Huahai Pharmaceutical Telmisartan and Hydrochlorothiazide Drug Product Offerings

Table 106. Huahai Pharmaceutical Recent Development

Table 107. Key Raw Materials Lists

Table 108. Raw Materials Key Suppliers Lists

Table 109. Telmisartan and Hydrochlorothiazide Drug Downstream Customers

Table 110. Telmisartan and Hydrochlorothiazide Drug Distributors List

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Telmisartan and Hydrochlorothiazide Drug Product Picture

Figure 2. Global Telmisartan and Hydrochlorothiazide Drug Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Telmisartan and Hydrochlorothiazide Drug Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume (2019-2030) & (K Units)

Figure 5. Global Telmisartan and Hydrochlorothiazide Drug Sales Price (2019-2030) & (USD/Unit)

Figure 6. Telmisartan and Hydrochlorothiazide Drug Report Years Considered

Figure 7. Global Telmisartan and Hydrochlorothiazide Drug Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Telmisartan and Hydrochlorothiazide Drug Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Telmisartan and Hydrochlorothiazide Drug Revenue in 2023

Figure 10. Telmisartan and Hydrochlorothiazide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. 80 mg/12.5 mg Tablets Picture

Figure 12. 40 mg/12.5 mg Tablets Picture

Figure 13. 80 mg/25 mg Tablets Picture

Figure 14. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Telmisartan and Hydrochlorothiazide Drug Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 17. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Telmisartan and Hydrochlorothiazide Drug Price by Type (2019-2030) & (USD/Unit)

Figure 19. Product Picture of High Blood Pressure (Hypertension)

Figure 20. Product Picture of Others

Figure 21. Global Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 22. Global Telmisartan and Hydrochlorothiazide Drug Sales Value Market Share by Application, 2023 & 2030

Figure 23. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 24. Global Telmisartan and Hydrochlorothiazide Drug Sales Volume Market Share by Application, 2023 & 2030

Figure 25. Global Telmisartan and Hydrochlorothiazide Drug Price by Application (2019-2030) & (USD/Unit)

Figure 26. North America Telmisartan and Hydrochlorothiazide Drug Sales Value (2019-2030) & (US$ Million)

Figure 27. North America Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

Figure 28. Europe Telmisartan and Hydrochlorothiazide Drug Sales Value (2019-2030) & (US$ Million)

Figure 29. Europe Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

Figure 30. Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales Value (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

Figure 32. South America Telmisartan and Hydrochlorothiazide Drug Sales Value (2019-2030) & (US$ Million)

Figure 33. South America Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

Figure 34. Middle East & Africa Telmisartan and Hydrochlorothiazide Drug Sales Value (2019-2030) & (US$ Million)

Figure 35. Middle East & Africa Telmisartan and Hydrochlorothiazide Drug Sales Value by Country (%), 2023 VS 2030

Figure 36. Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Value (%), (2019-2030)

Figure 37. Key Countries/Regions Telmisartan and Hydrochlorothiazide Drug Sales Volume (%), (2019-2030)

Figure 38. United States Telmisartan and Hydrochlorothiazide Drug Sales Value, (2019-2030) & (US$ Million)

Figure 39. United States Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

Figure 40. United States Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (%), 2023 VS 2030

Figure 41. Europe Telmisartan and Hydrochlorothiazide Drug Sales Value, (2019-2030) & (US$ Million)

Figure 42. Europe Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

Figure 43. Europe Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (%), 2023 VS 2030

Figure 44. China Telmisartan and Hydrochlorothiazide Drug Sales Value, (2019-2030) & (US$ Million)

Figure 45. China Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

Figure 46. China Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (%), 2023 VS 2030

Figure 47. Japan Telmisartan and Hydrochlorothiazide Drug Sales Value, (2019-2030) & (US$ Million)

Figure 48. Japan Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

Figure 49. Japan Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (%), 2023 VS 2030

Figure 50. South Korea Telmisartan and Hydrochlorothiazide Drug Sales Value, (2019-2030) & (US$ Million)

Figure 51. South Korea Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

Figure 52. South Korea Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (%), 2023 VS 2030

Figure 53. Southeast Asia Telmisartan and Hydrochlorothiazide Drug Sales Value, (2019-2030) & (US$ Million)

Figure 54. Southeast Asia Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

Figure 55. Southeast Asia Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (%), 2023 VS 2030

Figure 56. India Telmisartan and Hydrochlorothiazide Drug Sales Value, (2019-2030) & (US$ Million)

Figure 57. India Telmisartan and Hydrochlorothiazide Drug Sales Value by Type (%), 2023 VS 2030

Figure 58. India Telmisartan and Hydrochlorothiazide Drug Sales Value by Application (%), 2023 VS 2030

Figure 59. Telmisartan and Hydrochlorothiazide Drug Industrial Chain

Figure 60. Telmisartan and Hydrochlorothiazide Drug Manufacturing Cost Structure

Figure 61. Channels of Distribution (Direct Sales, and Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-19S7015

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Telmisartan and Hydrochlorothiazide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-13L7097

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Candesartan Cilexetil Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-4B7213

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Pravastatin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-34M6796

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Telmisartan and Hydrochlorothiazide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-13L7097

Telmisartan and Hydrochlorothiazide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

FEATURED COMPANIES

Telmisartan and Hydrochlorothiazide Drug - Market Size

Telmisartan and Hydrochlorothiazide Drug - Market

Report Scope

Scope of Telmisartan and Hydrochlorothiazide Drug - Market Report

Chapter Outline

FAQ for this report

What is the Telmisartan and Hydrochlorothiazide Drug - Market size in 2030?

Who are the main players in the Telmisartan and Hydrochlorothiazide Drug - Market report?

What are the Application segmentation covered in the Telmisartan and Hydrochlorothiazide Drug - Market report?

What are the Type segmentation covered in the Telmisartan and Hydrochlorothiazide Drug - Market report?

FEATURED COMPANIES

RELATED REPORTS